Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

186.16
Delayed Data
As of May 31
 -0.80 / -0.43%
Today’s Change
147.60
Today|||52-Week Range
270.63
-9.19%
Year-to-Date
MRK, SHPG And JNJ, Pushing Drugs Industry Downward
May 31 / TheStreet.com - Paid Partner Content
Baxalta Reports Positive Phase I Study Data on BAX 930
May 26 / Zacks.com - Paid Partner Content
Shire (SHPG) Gets Favorable CHMP Opinion for Revestive
May 31 / Zacks.com - Paid Partner Content
3 Stocks Underperforming Today In The Drugs Industry
May 26 / TheStreet.com - Paid Partner Content
Shire Expects to Wrap Up Baxalta Buy on June 3
May 27 / TheStreet.com - Paid Partner Content
British CEOs should take a 50% pay cut
May 20 / CNNMoney.com

Today’s Trading

Previous close186.96
Today’s open187.82
Day’s range185.00 - 189.24
Volume4,702,322
Average volume (3 months)2,553,251
Market cap$37.0B
Dividend yield0.73%
Data as of 3:59pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-61.89%
Earnings growth (this year)+9.89%
Earnings growth (next 5 years)+12.85%
Revenue growth (last year)+6.79%
P/E ratio27.6
Price/Sales6.33
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+0.48+0.32%
ZTSZoetis Inc+0.24+0.51%
VRTXVertex Pharmaceutica...+2.77+3.06%
MYLMylan NV+0.28+0.65%
Data as of 4:02pm ET, 05/31/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$3.09
Annual revenue (last year)$6.4B
Annual profit (last year)$1.3B
Net profit margin20.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs